Literature DB >> 32470397

Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.

Ekaterina Friebel1, Konstantina Kapolou2, Susanne Unger1, Nicolás Gonzalo Núñez1, Sebastian Utz1, Elisabeth Jane Rushing3, Luca Regli4, Michael Weller2, Melanie Greter1, Sonia Tugues1, Marian Christoph Neidert5, Burkhard Becher6.   

Abstract

Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations in the body (metastases). A highly immunosuppressive tumor microenvironment (TME) influences brain tumor outgrowth. Whether the TME is predominantly shaped by the CNS micromilieu or by the malignancy itself is unknown, as is the diversity, origin, and function of CNS tumor-associated macrophages (TAMs). Here, we have mapped the leukocyte landscape of brain tumors using high-dimensional single-cell profiling (CyTOF). The heterogeneous composition of tissue-resident and invading immune cells within the TME alone permitted a clear distinction between gliomas and brain metastases (BrM). The glioma TME presented predominantly with tissue-resident, reactive microglia, whereas tissue-invading leukocytes accumulated in BrM. Tissue-invading TAMs showed a distinctive signature trajectory, revealing tumor-driven instruction along with contrasting lymphocyte activation and exhaustion. Defining the specific immunological signature of brain tumors can facilitate the rational design of targeted immunotherapy strategies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cells; Tregs; brain metastases; exhaustion; glioma; macrophages; mass cytometry; microglia; monocytes; tumor microenvironment

Year:  2020        PMID: 32470397     DOI: 10.1016/j.cell.2020.04.055

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  142 in total

Review 1.  Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy.

Authors:  Eiichi Ishikawa; Tsubasa Miyazaki; Shingo Takano; Hiroyoshi Akutsu
Journal:  Brain Tumor Pathol       Date:  2021-05-11       Impact factor: 3.298

Review 2.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

Review 3.  Analyzing high-dimensional cytometry data using FlowSOM.

Authors:  Katrien Quintelier; Artuur Couckuyt; Annelies Emmaneel; Joachim Aerts; Yvan Saeys; Sofie Van Gassen
Journal:  Nat Protoc       Date:  2021-06-25       Impact factor: 13.491

4.  CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10.

Authors:  Ian H Guldner; Qingfei Wang; Lin Yang; Samantha M Golomb; Zhuo Zhao; Jacqueline A Lopez; Abigail Brunory; Erin N Howe; Yizhe Zhang; Bhavana Palakurthi; Martin Barron; Hongyu Gao; Xiaoling Xuei; Yunlong Liu; Jun Li; Danny Z Chen; Gary E Landreth; Siyuan Zhang
Journal:  Cell       Date:  2020-10-27       Impact factor: 41.582

Review 5.  The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.

Authors:  Hirotake Tsukamoto; Yoshihiro Komohara; Hiroyuki Oshiumi
Journal:  Hum Cell       Date:  2021-04-27       Impact factor: 4.174

6.  What is the Burden of Proof for Tumor Mutational Burden in gliomas?

Authors:  Mustafa Khasraw; Kyle M Walsh; Amy B Heimberger; David M Ashley
Journal:  Neuro Oncol       Date:  2020-11-30       Impact factor: 12.300

Review 7.  The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.

Authors:  Takahide Nejo; Abigail Mende; Hideho Okada
Journal:  Jpn J Clin Oncol       Date:  2020-10-22       Impact factor: 3.019

Review 8.  Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.

Authors:  Wenjing Xuan; Maciej S Lesniak; Charles David James; Amy B Heimberger; Peiwen Chen
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

Review 9.  The immune landscape of common CNS malignancies: implications for immunotherapy.

Authors:  Martina Ott; Robert M Prins; Amy B Heimberger
Journal:  Nat Rev Clin Oncol       Date:  2021-06-11       Impact factor: 66.675

Review 10.  A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system.

Authors:  Alexandros Marios Sofias; Francis Combes; Steffen Koschmieder; Gert Storm; Twan Lammers
Journal:  Drug Discov Today       Date:  2021-02-19       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.